Consultant Hepatologist and Honorary Clinical Senior Lecturer
Dr Jess Dyson is an NHS consultant hepatologist at Freeman Hospital in Newcastle, UK, with sub-specialty interests in autoimmune liver disease and liver transplantation. She leads the clinical service in Newcastle for patients with autoimmune liver disease and runs the regional service for second-line therapies for patients with high risk primary biliary cholangitis (PBC). She is also an honorary clinical senior lecturer at Newcastle University undertaking translational clinical research with a particular focus on autoimmune liver disease, risk stratification and identification of disease biomarkers. She is principal investigator for the UK national study for patients with autoimmune hepatitis (UK-AIH) that focuses on improving therapy for patients. She is a member of the BASL SIG for autoimmune liver disease and the IAIHG and IPSCSG. She completed her PhD in 2019 investigating potential environmental risk factors related to autoimmune liver disease. She is a co-author on the UK guidelines for PBC, primary sclerosing cholangitis (PSC) and autoimmune hepatitis (AIH).